wild-type eNOS, and in increased release of heme-bound dioxygen as a superoxide anion (SS Gross, personal communication).
In conclusion, the study by Cherney et al. , 3 though not completely resolving the mystery of Glu298Asp substitution in eNOS, does promote the idea of the functional liability of this polymorphism. However, one should recognize that a multitude of interpretations is buried within the super cial simplicity of the L -arginine challenge test. Future studies should address at least some of them by also using D -arginine infusion (to rule out non-substrate actions) and performing western blotting of eNOS using N and C terminus-recognizing antibodies (to examine tissues for the presence of eNOS fragments). In the future, all these e orts may become incorporated into individualized preventive medicine.
of HIF signaling appears to be a twoedged sword. Whereas proangiogenic and cytoprotective e ects of HIF-dependent mediators under certain chronic renal disease conditions may have a protective function, 3 HIF e ectors can be harmful; direct regulation of brinogenic factors, synergetic interaction with the pro brotic transforming growth factor-(TGF-), and the potential role of TGF-in epithelial-to-mesenchymal transition and in inflammation have the potential to perpetuate chronic kidney disease progression. 4 erefore, it is important to decode presumably cell type-and context-dependent HIF-related biological functions to develop therapeutic interventions that improve tissue oxygenation and halt the progression of brosis. Kojima et al. 5 (this issue) demonstrate encouraging functional interactions of the HIF pathway with other signaling pathways that are relevant for basal cell functions such as protein-translation control or cell survival and apoptosis. e approaches that the authors used to show the cross-links between HIF signaling and other major intracellular signaling
Metallothionein: a new soldier in the fight against chronic renal hypoxia?
Reinhard Bauer 1 A decline in renal oxygenation can precede matrix accumulation in chronic kidney diseases, suggesting that sustained ischemic hypoxia above the necrotic threshold may initiate and promote tubulointerstitial brosis. is can cause progressive renal dysfunction and tissue destruction, the nal common pathway leading to end-stage renal failure. 1 Consequently, hypoxia-inducible transcription factors (HIFs), the master switches of oxygen-dependent gene regulation, appear to play a crucial role in the dynamics and fate of poorly oxygenated renal tissue. In contrast to acute renal ischemiareperfusion injuries, wherein HIF target genes are mainly involved in cellular mechanisms that improve outcome by increased hypoxia tolerance or enhanced oxygen availability, 2 long-term activation see original article on page 268 1 pathways within the complex molecular pathogenesis of chronic kidney disease may be promising -for example, microarray analysis in well-designed animal models, which reflect the temporal sequence of an initial (mainly) pure hypoxic state of the injured kidney with subsequent evolving tissue destruction. Kojima et al. 5 used the unilateral renal artery stenosis model in rats and obtained cortical tissue samples at time points of sustained tissue hypoxia. is was veri ed using rats harboring a transgene composed of hypoxia response element (HRE) and the FLAG-tagged luciferase reporter gene, which indicates hypoxic cells by showing an HIF-mediated cellular hypoxic response. ey further identi ed altered expression patterns of 96 genes following renal artery stenosis, including those genes coding for growth factors, kinases, and adhesion molecules, and validated them by quantitative reverse transcription polymerase chain reaction. Among these, an upregulation of metallothioneins (MTs) was encountered and further analyzed.
Sustained hypoxia appears to be an early and pivotal condition in the pathogenesis of chronic kidney disease, and may induce a number of adaptive / protective or harmful cellular responses. Kojima and colleagues found an upregulation of metallothioneins (MTs) among dozens of altered expression patterns. They demonstrated the astonishing properties of MTs within major intracellular signaling pathways beyond their notorious functions in heavy metal metabolism, detoxification, and ROS scavenging -HRE stimulation during normoxia and hypoxia together with ERK phosphorylation and mTOR activation.
Indeed, these proteins, rich in cysteine ( ~ 30 % of the amino acids) and of low molecular weight (6 -7 kilodaltons), represent a group of non-enzymatic multifunctional proteins with multifaceted protective capacities due to a variety of cell-stress situations. MT-I and MT-II are the most prevalent of the four known MT isoforms; MT-III is expressed mainly in the brain, and MT-IV is expressed in certain squamous epithelia. is highly conserved family of closely related stress response proteins has the ability to bind and hence neutralize toxic (such as cadmium and mercury) and excess nontoxic (such as zinc and copper) heavy metal ions and is centrally involved in the homeostatic regulation of zinc concentration. MTs also act as potent radical scavengers and protect against electrophilic antineoplastic agents, various mutagens, ionizing radiation, and nitric oxide. ey are also highly inducible and transcriptionally activated by a variety of initiators, including divalent heavy metals, proinflammatory mediators, glucocorticoids, reactive oxygen and nitrogen species, and toxic organic compounds. 6 It is therefore not surprising that aberrant expression patterns of MT are correlated with a number of pathologic conditions, such as hypoxia. An intriguing feature of MT regulation is its involvement in the regulation of speci c transcription factor activity, such as that of HIF, as shown by prevailing evidence from studies on the molecular pathogenesis of solid tumor carcinogenesis. e fateful malignant progression heavily depends on oxygen deprivation-related aberrant modi cations of signaling pathways and their downstream transcription factors, induced by microenvironmental hypoxia due to malfunction and malformation of blood vessels. In a variety of carcinoma cell lines, MT is transcriptionally activated by hypoxia through metal response elements, binding metal transcription factor-I (MTF-I) in their proximal promoter regions, which is essential for basal promoter activity and for induction by hypoxia, although other elements contribute to the full transcriptional response. Subsequently, sustained hypoxia results in an interplay between HIF-1 and MTF-I as a central regulator of metal-inducible expression of MT-I and MT-II. Indeed, MTF-I participates in the stabilization and nuclear accumulation of the HIF-1 protein. A recent study provides evidence for recruitment of MTF-I, HIF-1 , and p300 to the MT-I promoter and indicates that MTF-I and HIF-1 are components of a transcriptional complex in response to hypoxia. 7 ereby, a marked accumulation of MT appeared in the hypoxic cells. A similar crosstalk by transactivation between MTF-I and HIF-1 in the hypoxic kidney remains to be elucidated.
Nevertheless, in immortalized rat proximal tubular cells, the authors observed a surprising e ect of administration of MT-I into the medium. Upregulation of HRE activity occurred under normoxic as well as hypoxic conditions and in a dosedependent manner, followed by increased activity of representative HIF target genes, such as encoding for VEGF, Glut-1, and HO-1. is raised the question of how the HIF complex can be stabilized by MT administration. HIF-1 (expressed in kidney tubular epithelial cells) and HIF-2 (expressed in glomerular cells, peritubular endothelial cells, and interstitial broblasts) are members of the Per-ARNT-Sim family of basic helix-loop-helix transcription factors and consist of an oxygen-sensitive -subunit and a constitutively expressed -subunit, also known as the aryl hydrocarbon-receptor nuclear translocator or simply HIF-. HIF activation is dependent on stabilization of the oxygensensitive -subunit and its subsequent translocation to the nucleus, where it dimerizes with HIF-and recruits transcriptional cofactors such as CBP and p300. 8 Under conditions of adequate oxygen supply, hydroxylated HIF-binds to the von Hippel-Lindau tumor suppressor protein (pVHL), which is part of an E3 -ubiquitin ligase complex that targets HIF-for proteasomal degradation. e pVHL -HIF-interaction is highly conserved between species and requires iron-and oxygen-dependent hydroxylation of two speci c proline residues within the oxygen-dependent degradation domain of HIF-. Prolyl-hydroxylation by prolyl hydroxylase domain (PHD) proteins and binding to pVHL are absolutely required for the execution of HIF proteolysis under normoxia. e second type of oxygen sensor controlling the hypoxic response is an asparaginyl hydroxylase, referred to as factor inhibiting HIF-1 (FIH). is enzyme hydroxylates an asparagine residue in the most carboxy-terminal transcriptional activation domain (C-TAD) of human HIF-1 . is covalent modi cation abrogates C-TAD interaction with transcriptional coactivators, such as p300 and its paralogue CBP. us, the two metabolic sensors, PHD and FIH, by controlling both the destruction and the inactivation of HIF-subunits, ensure full repression of the HIF pathway in welloxygenated cells. 9 Because Kojima and co-workers 5 eliminated a possible iron-chelating e ect of MT by inducing HIF activation under normoxia, other essential components of HIF-degradation must now be inhibited. Whether a direct protein -protein interaction between HIFand MT (described for the intracellular domain of Notch, which underscores the importance of HIF-as a regulator of important intracellular pathways, independent of its role in HRE-mediated transcription) or other factors (such as cellular ascorbate depletion resulting in oxidant stress and PHD inhibition) could be responsible remains to be clari ed.
Kojima and co-workers 5 describe another intriguing observation ( Figure 1 ) : an inhibitory in uence of rapamycin on HRE activity during MT-I stimulation under both normoxic and hypoxic conditions, suggesting a speci c MT-I-induced and mTOR-mediated transcriptional stimulation of HIF target genes. As a chief orchestrator of protein synthesis to regulate cell growth and metabolism in response to environmental cues, the mTOR pathway integrates a variety of signals downstream from growth factors as well as nutrient inputs in the form of amino acid, glucose, and oxygen availability. Because rapamycin strongly inactivates mTOR signaling via the mTORC1 complex (raptor, which controls translation of critical growth genes including HIF1A ), it appears reasonable that MT can displace an inhibitory e ect of hypoxia on mTOR signaling. In contrast, oxygen deprivation resulting in ATP depletion increased the AMP:ATP ratio with related AMP protein kinase activation and tuberin (TSC2) phosphorylation and thereby caused mTORC1 inhibition. Furthermore, hypoxia is transduced to mTORC1 via the two homologous proteins REDD1 and REDD2. e expression of REDD is upregulated upon hypoxia by the transcription factor HIF-1. REDD acts downstream of Akt and upstream of TSC1-TSC2 to inhibit mTORC1 signaling. 11 e observation that MT-I stimulation activated the ERK1 / 2 but not the PI3 / Akt pathway demonstrates the need for an in-depth analysis to clarify the presumptive target mechanism of the novel defense potential of MT in protecting against chronic hypoxia in the kidney.
